We are live on ! Find out more
ACRS icon

Aclaris Therapeutics
ACRS

128 hedge funds and large institutions have $1.04B invested in Aclaris Therapeutics in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 45 increasing their positions, 37 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more call options, than puts

Call options by funds: $483K | Put options by funds: $362K

22% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 37

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

8% more capital invested

Capital invested by funds: $957M → $1.04B (+$78.3M)

3.32% more ownership

Funds ownership: 95.35% → 98.67% (+3.3%)

1% more funds holding

Funds holding: 127 → 128 (+1)

33% less funds holding in top 10

Funds holding in top 10: 9 → 6 (-3)

Holders
128
Holders Change
+1
Holders Change %
+0.79%
% of All Funds
2.06%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.1%
New
13
Increased
45
Reduced
37
Closed
11
Calls
$483K
Puts
$362K
Net Calls
+$121K
Net Calls Change
+$116K

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$32.7M
2
BlackRock
BlackRock
New York
+$4.48M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.07M
4
Walleye Capital
Walleye Capital
New York
+$2.4M
5
HighTower Advisors
HighTower Advisors
Illinois
+$2.16M

Top Sellers

1
BI
BVF Inc
California
-$11.3M
2
CC
Commodore Capital
New York
-$8.53M
3
Holocene Advisors
Holocene Advisors
New York
-$6.39M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$6M
5
ACM
Aisling Capital Management
New York
-$3.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Allianz Asset Management
76
Allianz Asset Management
Germany
$343K – – –
Balyasny Asset Management
77
Balyasny Asset Management
Illinois
$323K -$1.38M -85,644 -81%
Legal & General Group
78
Legal & General Group
United Kingdom
$317K +$7.8K +485 +2%
State Board of Administration of Florida Retirement System
79
State Board of Administration of Florida Retirement System
Florida
$294K +$3.06K +190 +1%
Citigroup
80
Citigroup
New York
$288K +$161K +10,003 +121%
Principal Financial Group
81
Principal Financial Group
Iowa
$287K +$29.1K +1,811 +11%
Connor, Clark & Lunn Investment Management (CC&L)
82
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$265K -$161K -10,008 -37%
FRM
83
Fox Run Management
Connecticut
$258K +$22.9K +1,422 +10%
XSC
84
X-Square Capital
Puerto Rico
$252K – – –
Cambridge Investment Research Advisors
85
Cambridge Investment Research Advisors
Iowa
$242K -$3.22K -200 -1%
AIMCA
86
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$238K -$10.7K -663 -4%
Handelsbanken Fonder
87
Handelsbanken Fonder
Sweden
$233K +$238K +14,800 New
ECM
88
ExodusPoint Capital Management
New York
$232K +$237K +14,753 New
AQR Capital Management
89
AQR Capital Management
Connecticut
$226K +$51.1K +3,174 +28%
AG
90
Algert Global
California
$218K +$222K +13,830 New
ProShare Advisors
91
ProShare Advisors
Maryland
$218K +$17.7K +1,098 +9%
ASRS
92
Arizona State Retirement System
Arizona
$207K +$8.11K +504 +4%
Blackstone Inc
93
Blackstone Inc
New York
$205K – – –
XT
94
XTX Topco
Cayman Islands
$196K +$200K +12,423 New
HCA
95
Hyperion Capital Advisors
New York
$171K – – –
Two Sigma Investments
96
Two Sigma Investments
New York
$169K +$172K +10,700 New
AB
97
Amalgamated Bank
New York
$165K – – –
Zurich Cantonal Bank
98
Zurich Cantonal Bank
Switzerland
$154K +$36.3K +2,258 +30%
BNP Paribas Financial Markets
99
BNP Paribas Financial Markets
France
$142K -$194K -12,080 -57%
ACM
100
Aquatic Capital Management
Illinois
$139K +$142K +8,800 New
2 3
4
5 6

ACRS Hedge Fund Activity: Q4 2022 in Review

128 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Aclaris Therapeutics (ACRS) for Q4 2022, worth a combined $1.04B — up 8.2% from $957M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ACRS positions and 11 closed out — a net gain of 2 holders — while 45 added to existing stakes and 37 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $32.7M. The largest seller was BVF Inc, cutting an estimated $11.3M.

  • 128 institutional investors held Aclaris Therapeutics (ACRS) as of Q4 2022, up from 127 in Q3 2022.
  • Funds reported $1.04B of Aclaris Therapeutics stock for Q4 2022, up 8.2% quarter-over-quarter.
  • 13 funds opened new Aclaris Therapeutics positions in Q4 2022 and 11 closed out, a net change of +2 holders.
  • The largest Aclaris Therapeutics buyer in Q4 2022 was Wellington Management Group, an estimated $32.7M added.
  • The largest Aclaris Therapeutics seller in Q4 2022 was BVF Inc, an estimated $11.3M sold.

Based on aggregated 13F filings for Q4 2022.